Notice: Function wp_enqueue_script was called incorrectly. Scripts and styles should not be registered or enqueued until the wp_enqueue_scripts, admin_enqueue_scripts, or login_enqueue_scripts hooks. This notice was triggered by the nfd_wpnavbar_setting handle. Please see Debugging in WordPress for more information. (This message was added in version 3.3.0.) in /home3/mwebb/public_html/wp-includes/functions.php on line 6078

Deprecated: Function jetpack_form_register_pattern is deprecated since version jetpack-13.4! Use Automattic\Jetpack\Forms\ContactForm\Util::register_pattern instead. in /home3/mwebb/public_html/wp-includes/functions.php on line 6078
Cancer Registry News and Updates - Cancer Registrar

Cancer Prevention 2021 (infographic)

Cancer Prevention 2021 (infographic)

The American Cancer Society (ACS) conducts long-term studies on how research helps people to understand, prevent, and treat cancer. Research helps to identify links between a behavior or lifestyle and an individual’s risk of getting cancer. For example, cigarette smoking and lung cancer, or the impact of being overweight or obese on cancer incidence or death, and so forth.

Cancer Registrars collaborate with physicians, nurses and administrators to plan and conduct cancer prevention and screening events. They use information from research to identify what we have learned from research and to develop prevention events and educational topics that are targeted uniquely to the community.

The ACS infographic (see below) is a useful resource that can be used by Cancer Registrars and community outreach coordinators as they plan their cancer prevention events in 2021.

Her2+ Metastatic Breast Cancer

Her2 is a growth-promoting protein found on the outside of all breast cells. If they have a higher than normal level of Her2 they are called Her2-positive. Her2+ breast cancers tend to grow and spread faster than other breast cancers, but are also more likely to respond to treatment with drugs that target the Her2 protein. Women with newly diagnosed invasive breast cancers should be tested for Her2. According to the American Cancer Society, testing is usually done at the time of the biopsy and is usually tested with either immunohistochemical stains (IHC) or Fluorescent in situ hybridization (FISH).

The National Comprehensive Cancer Network, or NCCN, has released two patient educational videos on Her2+ metastatic breast cancer that we have included for you below. Cancer Registrars may also find these videos to be informative.

Lessons Learned from COVID-19

ACCC (Association of Community Cancer Centers) has reaffirmed its commitment to integrating health equity, diversity, and inclusion into its advocacy for cancer patients. ACCC has a long-standing history of developing opportunities to increase racial and ethnic minority clinical representation; advocating for reimbursement and coverage of telemedicine and virtual health services and in supporting the professional well-being of the cancer team to improve provider and patient satisfaction.

The infographic below was recently published and summarizes some of the lessons learned in the clinical and administrative setting during and after the pandemic.

To read the entire article, click here.

Distance from Hospital Impacts Cancer Diagnosis and Survival in Young Adults

Adolescents and young adults who live in rural vs metropolitan counties in the United States, and further away from hospitals, are more likely to be detected at a later cancer stage, and have lower survival rates, as compared to those living in metropolitan counties and close to the hospital.

In a recent study from the Brown School at Washington University, “A number of studies have indicated that place of residence can influence cancer survivoral, however, few studies have specifically focused on geographic factors and outcomes in adolescents and young adults with cancer.”

Using the National Cancer Database (NCDB) records, over 180,000 records for adolescents and young adults were analyzed, ages 15-39 years who were diagnosed with cancer from 2010-2014. The results determined that residence in metro, urban or rural counties at the time of diagnosis. Distance between the patient’s residence and the reporting hospital was categorized as short (< 12.5 miles), intermediate (between 12.5-50 miles) and long (> 50 miles).

Study results found that adolescents and young adults living in rural counties had a 1.16 to be diagnosed at a later stage and 1.2 times greater if they were living at a long vs short distance from the hospital. Death rates were 1.17 times greater for those living in rural versus metropolitan counties and 1.30 times greater for long versus short distances from the reporting hospital.

Researchers at Brown hope to continue to evaluate geographic disparities in cancer care to understand the mechanisms for these findings and to encourage interventions to address them.

For cancer registrars working in accredited programs, use of the CQIP reports may offer opportunities for the Cancer Committee to look at these geographic and age-related disparities at your local facility.

To view the original article, click here.

Best Practice Series for Cancer Registrars

The National Cancer Registrar’s Association (NCRA) launched a new information series, titled “NCRA Best Practice Guidance Series” in April 2021. As the industry leader in cancer registry salary and workforce research, NCRA has teamed up with partner organizations to identify the needs, launch initiatives and coordinate studies that will promote outcomes. Much of this work has been designed to share national workload and time management data relevant for hospital- and central cancer registry based Registrars.

The NCRA Best Practice Guidance Series is the first of a series NCRA plans to release that will organize and deliver a structured set of information on a variety of cancer registry workforce procedures, management and activities to guide cancer registry operations and staffing needs.

The first resource to be launched in this series, titled “Why Your Staff are Your Top Resource When Considering Outsourcing Services in Support of the Cancer Registry” was released in April, 2021. Additional resources will be released as they become available.

To download the NCRA Best Practice Guidance Series: Why Your Staff Are Your Top Resource When Considering Outsourcing Services in Support of the Cancer Registry, click here to be redirected to the NCRA webpage.

7 Signs Your Cancer Registry is Performing Well

“The cancer registry network is a powerful resource in oncology healthcare. The connections and relationships with members of the cancer care team are a valuable source of knowledge and provide many opportunities for resource-sharing and growth. The cancer registry should never be maintained solely for the purpose of meeting minimum reporting requirements. Instead, it should be a vital part of the facility’s cancer delivery system and be in alignment with the strategic plan and mission.”

To read the rest of this article click here to be redirected to the MRA website. There is free bonus material available too!

What is a Cancer Registrar?

Cancer Registrars are highly trained data management health professionals who collect, classify, and analyze cancer information. Their primary focus in on the cancers diagnosed and/or treated at the facility where they work or with another defined population or subset of patients.

Data collection and management is a complex process that requires extensive training and collaboration with the cancer standard-setting agencies. Each new diagnoses of cancer within the facility is carefully abstracted and data coded and classified according to multiple standards and guidelines. From the date of diagnoses, and for the remainder of the patient’s life, data is collected and used to determine if the diagnostic and treatment methods used by providers is effective and survival rates.

The cancer registrar’s work goes far beyond keeping the data (i.e., curation) accurate and complete. They also work closely with physicians, advanced practice providers, allied health professionals, administrators, clinical researchers and other members of a facility’s leadership teams to provide data and support for the cancer program. They collaborate and support the conduct of cancer-related quality studies and improvements, evaluation of the facility’s concordance with evidence-based medicine and guidelines and are required members of the facility’s Cancer Committee and other selected workgroups.

As a curator, the cancer registrar is also accountable for monitoring and overseeing the data collection process and discovering opportunities for cancer program improvements, staying current with the cancer-directed and relevant practices in medicine, publications, webinars and community needs.

Ongoing professional education is critical to the Cancer Registrar’s long term success. Clinical and scientific information is changing at a rapid pace and the Registrar must be self-motivated and committed to continuing education. By seeking out and participating in a broad range of continuing education activities, the Cancer Registrar expands their skill sets and ensures that they are a value-added member of the collaborative cancer team.

What is a Cancer Registry?

What is a cancer registry? Well, it is a structured department, program or system usually found in hospitals and medical clinics. The cancer registry is an information gathering system, staffed by Cancer Registrars, to collect, manage, and analyze demographic and health information on patients who have been diagnosed or treated with cancer and some benign tumors or neoplastic diseases.

Cancer Registries are classified into three different types:

  • Hospital Registries who maintain data on all patients diagnosed or treated for cancer at that facility. Facility-specific data is usually submitted to a state-funded or central cancer registry as required by law.
  • Central Cancer Registries are population-based registires that gather data from the hospitals and medical clinicals and then maintain that data on all cancer patients within their geographic area.
  • Special Purpose Registries collect and maintain data on a particular type of cancer, such as brain tumors or hematologic conditions.

We’re Back ….

CancerRegistrar.com, and CancerRegistry.com, is back! The website was down due to an unexpected technical error and remained in hiatus for a while. But, we are back and have no intention of going anywhere for a very long time! We appreciate your patience as we build a brand new website packed full of information and resources focused on the cancer registrar’s career and work.

Please tell your friends about us and take your time browsing the various pages and resources as we add them to the site.